Morbidity and Mortality Patterns in Children Admitted to Hospital in Thai Binh, Vietnam: A Five-year Descriptive

Thi Dung Pham1, Van Thuan Hoang1,2,3, Thi Loi Dao1,2,3

  • 1Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.

Insights

Infectious diseases are the leading cause of illness and death in children at Thai Binh Paediatric Hospital. Improved diagnostic tools are needed for better treatment and antibiotic use.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Children in Vietnam face significant morbidity and mortality.
  • Infectious diseases are a major contributor to pediatric health issues.

Purpose of the Study:

  • To describe pediatric morbidity and mortality patterns at Thai Binh Paediatric Hospital.
  • To identify the prevalence of infectious diseases in hospitalized children.
  • To inform the need for improved diagnostic tools and antibiotic stewardship.

Main Methods:

  • Retrospective review of 113,999 hospitalization records from January 2015 to December 2019.
  • Analysis of patient demographics, diagnoses, treatment, and outcomes.
  • Focus on infectious disease patterns and their contribution to mortality.

Main Results:

  • Infectious diseases comprised 61.0% of cases, with lower respiratory tract infections being most common.
  • Antibiotics were administered to 81.4% of patients, often without microbiological documentation.
  • Infectious diseases accounted for 40.4% of deaths, highlighting a critical need for better diagnostics.

Conclusions:

  • Pediatric infectious diseases pose a substantial burden in Vietnam.
  • There is a clear need for enhanced diagnostic capabilities, such as point-of-care tests.
  • Improved diagnostics can lead to more accurate diagnoses and appropriate antibiotic use, reducing mortality.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
613
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
373
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
145
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
166
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131